LL-37 is the human cathelicidin antimicrobial peptide studied for immune defense. It is researched most often for Antimicrobial defense, Wound healing and Immune modulation. Active area of preclinical research. This guide walks through what LL-37 is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is LL-37?
LL-37 is the active form of the human cathelicidin antimicrobial peptide. It plays a role in innate immunity, with research covering antimicrobial activity, wound healing and immune modulation.
Also known as: Cathelicidin, CAP-18.
How does LL-37 work?
LL-37 is the active form of the human cathelicidin antimicrobial peptide, a part of the innate immune system. Research covers its antimicrobial activity, roles in wound healing, and immune modulation — though at high levels it has also been linked to inflammatory conditions.
What is LL-37 researched for?
In the research and community discussion, LL-37 comes up most often in connection with Antimicrobial defense, Wound healing and Immune modulation. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Antimicrobial defense
- Wound healing
- Immune modulation
What does the research actually show?
Active area of preclinical research. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting LL-37 as a guaranteed treatment is getting ahead of the evidence.
Safety and considerations
At high levels it has been linked to inflammatory conditions in research. Human therapeutic data is limited. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about LL-37
To go deeper, see the LL-37 library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where LL-37 might fit your goals.
Frequently asked questions
Antimicrobial defense, wound healing, and immune modulation. It is an active area of preclinical research.
Not necessarily — while it supports immune defense, elevated levels have been associated with certain inflammatory conditions in research.
No. Human therapeutic data is limited and it is not an approved therapy.
Not sure if LL-37 fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.